LONZA
Desconocido
RealHOPE: Real World Handling of Protein Drugs Exploration Evaluation and Education
LONZA AG
participó en un
H2020:
H2020-JTI-IMI2-2020-20-two-stage
RealHOPE will create an understanding of the real-life handling of protein drugs in hospital pharmacy, clinics and in the hands of patients...
2021-07-05 - 2025-06-30 | Financiado
2021-07-05 - 2025-06-30 | Financiado
ARDAT: Accelerating Research Development for Advanced Therapies
LONZA AG
participó en un
H2020:
H2020-JTI-IMI2-2019-18-two-stage
Major current hurdles for wide clinical use of AAV vectors are attributable primarily to: (i) host elimination by both immune and non-immune...
2020-11-11 - 2025-10-31 | Financiado
2020-11-11 - 2025-10-31 | Financiado
Secreters: A new generation of microbial expression hosts and tools for the production of biotherapeutics and h...
LONZA AG
participó en un
H2020:
H2020-MSCA-ITN-2018
The ‘SECRETERS’ partnership aims to bring about a step change in the production of recombinant proteins, particularly Biotherapeutics and In...
2018-08-30 - 2023-06-30 | Financiado
2018-08-30 - 2023-06-30 | Financiado
EPOS: Enhanced energy and resource Efficiency and Performance in process industry Operations via onsite an...
LONZA AG
participó en un
H2020:
Out of the community created by SPIRE covering industrial and research actors throughout Europe, the EPOS project brings together 6 global p...
2015-07-20 - 2019-09-30 | Financiado
2015-07-20 - 2019-09-30 | Financiado
RRD4E2: Rational Reactor Design for Enhanced Efficiency in the European Speciality Chemicals Industry
LONZA AG
tramitó un
FP7:
"This project aims at a significant increase in the ecological and economic efficiency of today’s chemical processes by means of rational re...
Financiado
Financiado
P4FIFTY: Development of Cytochrome P450 Enzymes for the Chemical Manufacturing Industries
LONZA AG
participó en un
FP7:
The objective of the P4FIFTY project is to deliver a trans-European network of industrially oriented white biotechnologists fully trained in...
Financiado
Financiado
FORTISSIMO: Factories of the Future Resources Technology Infrastructure and Services for Simulation and Modell...
LONZA AG
participó en un
FP7:
The importance of advanced simulation to the competitiveness of both large and small companies is well established. The principal objective...
Financiado
Financiado
NEMOPUR: New Molecular Purification Technology for Pharmaceutical Production
LONZA AG
participó en un
FP7:
The NEMOPUR Initial Training Network will focus on creating a new generation of molecular purification technologies for Active Pharmaceutica...
Financiado
Financiado
BYEFOULING: Low toxic cost efficient environment friendly antifouling materials
The BYEFOULING project will address high volume production of low toxic and environmentally friendly antifouling coatings for mobile and sta...
Financiado
Financiado
MEMTIDE: Membrane Enhanced Tide Synthesis A New Paradigm Peptide Oligonucleotide Synthesis Technology
LONZA AG
participó en un
FP7:
The MemTide Initial Training Network will create a new generation of synthesis technologies for peptide and oligonucleotide (tide) manufactu...
Financiado
Financiado
* No se disponen de datos de la empresa actual.